MNTA Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: MNTA Shares Outstanding History and MNTA YTD Return |
MNTA Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: MNTA Shares Outstanding History and MNTA YTD Return |
MNTA Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
+18.45% CAGR Mouse over chart for data details
|
MNTA Stock Price Chart |
About Momenta Pharmaceuticals Inc |
Momenta Pharmaceuticals is a biotechnology company focused on the discovery and development of biologic therapies for the treatment of rare immune-mediated diseases. Co.'s programs include: M281, a fully-human anti-neonatal Fc receptor, aglycosylated immunoglobulin G (IgG1), monoclonal antibody; M254, a hyper-sialylated immunoglobulin; M230, a novel recombinant trivalent human IgG1 Fc multimer; and M710, a biosimilar of EYLEA, a vascular endothelial growth factor inhibitor indicated for the treatment of Neovascular (Wet) Age-related Macular Degeneration, Macular Edema following Retinal Vein Occlusion, Diabetic Macular Edema (DME), and Diabetic Retinopathy in patients with DME. We show 46 historical shares outstanding datapoints in our MNTA shares outstanding history coverage, used to compute MNTA market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing MNTA market cap history over the course of time is important for investors interested in comparing MNTA's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of MNTA versus a peer is one thing; comparing MNTA market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like MNTA can fluctuate over the course of history. With this page we aim to empower investors researching MNTA by allowing them to research the MNTA market cap history. |
MNTA Current Stock Quote |
Free MNTA Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: The Importance of Market Cap | |
|
MNTA Share Performance |
Market Cap Peers |
Momenta Pharmaceuticals (MNTA) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
MODD Market Cap History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.